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1078–5884/00End-to-end Versus End-to-side Distal Anastomosis in
Femoropopliteal Bypasses; Results of a Randomized
Multicenter Trial
O. Schouten,1 M.T.C. Hoedt,2 C.H.A. Wittens,3 W.C.J. Hop,4 M.R.H.M. van Sambeek,1
H. van Urk1* and on Behalf of the VASCAN Study GroupDepartments of 1Vascular Surgery, Erasmus MC, Rotterdam, 2Surgery, Albert Schweitzer Hospital,
Dordrecht, 3Surgery, Sint Fransiscus Gasthuis, and 4Biostatistics, Erasmus MC, Rotterdam, The NetherlandsObjective. To compare end-to-side (ETS) and end-to-end (ETE) distal anastomoses for femoropopliteal bypasses.
Design. Prospective, randomized, multicenter trial.
Methods. Patients from 14 centers were randomized to either ETS or ETE distal anastomosis, with stratification according
to center and four categories: venous and prosthetic above knee bypass, and venous and prosthetic below knee bypass. Follow-
up, with history, physical examination, ankle-brachial pressure index and duplex scan was performed at 3 months, 6 months
and every 6 months thereafter until 36 months postoperatively.
Results. A total of 328 femoropopliteal bypass operations were performed in 274 patients. Due to anatomical considerations
at the time of surgery, 15 procedures (4.6%) were excluded from further analysis. Patient characteristics, cardiovascular risk
factors, Rutherford classification and number of open run-off vessels were similar for both groups. Primary patency was 75
vs 74%, 65 vs 66% and 63 vs 55% for ETE vs ETS after 1, 2 and 3 years, respectively, (pZ0.26). During follow up major
amputations were necessary in 20 ETE bypasses and in nine ETS bypasses (pZ0.028).
Conclusion. ETE distal anastomosis in femoropopliteal bypasses does not improve patency compared to ETS anastomosis.
Major amputations, after failure of the bypass, were required more frequently for ETE distal anastomoses.Keywords: Femoropopliteal bypass; Anastomosis; Patency; Limb salvage.Introduction
Most medium and late graft failures in femoropopli-
teal bypass surgery are attributed to intimal hyper-
plasia (IH), in particular to IH within the anastomotic
region.1 The development of IH is related to haemo-
dynamic and humoral factors but is incompletely
understood.2–4 Wall shear stress (WSS) may play a
pivotal role in this IH formation. It has been suggested
that low and/or oscillating gradients of WSS trigger
the formation of IH.5–7 This WSS distribution can be
modified mechanically by using anastomotic tech-
niques different from the standard end-to-side (ETS)
anastomoses, such as end-to-end (ETE) and cuffed
anastomoses.
In in vitro studies, ETE anastomoses appear to haveng author. Prof Dr H. van Urk, Department of Vascular
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with regard to the WSS within the anastomotic
region.4,8 These experimental models show that ETS
anastomoses have three areas at risk for IH formation:
the bed (oscillating WSS), the toe (low/reversed WSS)
and the heel (low WSS) of the anastomosis.9 Inlay ETE
anastomoses on the other hand evade the problems of
bed, toe and heel sites, resulting in only two minor
regions with disadvantageous wall shear stress
distribution.8
The in vitro experiments suggest that ETE
anastomoses have a more favourable wall shear
stress distribution than ETS anastomoses. Thus,
hypothetically, ETE anastomoses may result in less
intimal hyperplasia formation and, therefore, in
improved patency of femoro-popliteal bypasses.
However, so far only one retrospective study has
been conducted to evaluate the differences in
patency and limb salvage between ETE and ETS
distal anastomoses for femoro-popliteal bypass.
This showed a trend (pZ0.09) toward improvedEur J Vasc Endovasc Surg 29, 457–462 (2005)
doi:10.1016/j.ejvs.2005.01.010, available online at http://www.sciencedirect.com onved.
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difference in the complications.10
Therefore, we conducted a multicenter, prospective,
randomized trial to clarify the potential benefits of
distal ETE anastomoses over distal ETS anastomoses:
the VASCular ANastomosis (VASCAN) trial.MethodsParticipants
Patients, 18 years or older, with Rutherford I–III/Fon-
taine II–IV, scheduled for prosthetic or venous above
knee or below knee bypass surgery for peripheral
arterial disease were included, and signed informed
consent for the VASCAN-trial. Patients with an acutely
threatened, ischaemic leg, a bypass to an isolated
popliteal segment, a bypass necessitated by trauma, a
life expectancy of less than 3 years or a contra-
indication to the use of anticoagulants were excluded.
Recruitment of patients took place in 14 hospitals
(one academic, six teaching hospitals and seven
community hospitals) between January 1997 and
January 2001.Surgical procedure
Choice of bypass material (venous or prosthetic) and
site of distal anastomosis was at the discretion of the
surgeon. In all ‘prosthetic’ operations, a 6 mm thin
walled FEP ringed Goretex PTFE (W.L. Gore, Flagstaff,
Ariz., USA) prosthesis was used.
ETE anastomoses were performed by transecting
and proximally ligating the popliteal artery or super-
ficial femoral artery. Then, the distal end of the artery
was spatulated over a distance of approximately twice
the diameter of the vessel. The two rectangular corners
were cut arcuated. The anastomosis was then com-
pleted by continuous suturing, with prosthetic Gore
CV-6/7 grafts.
For ETS anastomoses, the PTFE or venous bypass
was cut in a similar way as for the ETE-anastomosis.
Then, the artery was opened by a longitudinal incision
of approximately 12–15 mm, the PTFE or venous
bypass was cut curved in such a way that the bypass
could be placed in a 308 angle, and with continuous
suturing, using Gore CV 6/7 for prosthetic bypasses,
the bypass and artery were anastomosed.
Postoperative anticoagulant or antiplatelet therapy
was given, based on the preference of the surgeon.Eur J Vasc Endovasc Surg Vol 29, May 2005Objectives
The objective of this trial was to clarify the potential
benefits of distal ETE anastomosed femoropopliteal
bypasses over distal ETS anastomoses. We expected an
improved patency rate in ETE anastomosed bypass
with a similar complication and amputation rate after
failure of the bypass.Outcomes
The primary outcome of the VASCAN-trial was the
primary patency rate at 36 months postoperatively.
Patency was confirmed by duplex scanning whenever
possible. If a duplex scan was not feasible, patency
was confirmed by a combination of history, physical
examination and ankle brachial pressure index
measurements (ABPI). In case of uncertainty of
patency or marked deterioration of the ABPI, i.e.
decrease of more than 15% angiography was per-
formed. The date of occlusion was defined as the date
on which loss of patency was confirmed by either
duplex scanning or angiography. Patency was noted
on case record forms during follow-up visits. The
follow-up visits were scheduled 3 months after the
surgical procedure, 6 months after surgery and every 6
months thereafter until the follow-up period of 36
months was completed. In case of a symptomatic
occlusion of the bypass between two follow-up visits
an event form was filled out.
Secondary outcomes were the effect of both anasto-
motic techniques on (1) perioperative complications
including early failure of the bypass, re-interventions
and wound complications, and (2) the necessity of
amputation and level of amputation after graft failure.
Amputations were divided in minor and major
amputations. Major amputations were considered to
be below knee, through knee and above knee
amputations. Before surgery as well as in the
perioperative and follow-up period, case record and
event forms were used to record baseline, periopera-
tive and follow-up data, including medical history,
clinical parameters, results of angiography, ABPI,
perioperative complications, interventions, non-recon-
structive and ablative procedures, and patency of the
bypass.Sample size
Two groups of 160 patients each were needed to prove
a difference of 15% in primary patency rate after 3
years with a power of 90% and an a of 0.05.
Table 1. Baseline characteristics
ETE, NZ162 ETS, NZ166
Male 100 (62%) 96 (58%)
Age (years) 69 (39–90) 69 (39–90)
Angina pectoris 33 (21%) 32 (19%)
Myocardial infarction 41 (26%) 40 (24%)
TIA or CVA 19 (12%) 19 (11%)
Vascular interventions 72 (45%) 80 (48%)
Smoking 88 (55%) 94 (56%)
Hypertension 66 (41%) 77 (46%)
Diabetes mellitus 46 (29%) 48 (29%)
Hypercholesterolemia 27 (17%) 25 (15%)
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Randomization to either ETE or ETS distal anastomo-
sis was performed by center and patients were
stratified into four categories: venous and prosthetic
above knee bypass and venous and prosthetic below
knee bypass using a computer generated list, made by
the participating statistician (W.H.). On the day of
surgery participating surgeons were notified by tele-
phone what technique his or her patient was random-
ized to.ETE, end-to-end; ETS, end-to-side; TIA, transient ischemic attack;
CVA, cerebrovascular accident.Blinding
For obvious reasons, the surgeon could not be blinded
for treatment assignment. The laboratory technicians
performing the duplex scan to assess patency were
also not blinded, neither were the patient nor the
principal investigators (O.S. and M.T.C.H.).Statistical method
Kaplan–Meier survival curves were constructed to
assess patency rate, and limb salvage. A comparison of
these curves was made using the log-rank-test. Chi-
square analysis was used to compare percentages,
while the Mann–Whitney U-test was used to compare
outflow scores. Multivariate (Cox) regression was
used to compare patency and limb salvage in ETE
and ETS groups. Variables with a p-value of!0.1 were
entered in the multivariate analysis. A p-value of .05
(two-sided) was considered the limit of significance.ResultsTable 2. Distribution of Rutherford classification and number of
open run-off vessels
ETE, NZ162 ETS, NZ166
Rutherford I 93 (57%) 95 (57%)
II 37 (23%) 31 (19%)
III 32 (20%) 40 (24%)
Run-off 0 7 (4%) 4 (2%)
1 38 (24%) 36 (22%)
2 52 (32%) 50 (30%)
3 65 (40%) 76 (46%)
ETE, end-to-end; ETS, end-to-side.Baseline characteristics
A total of 328 bypass operations were performed in
274 patients. Fifty-four (16%) patients underwent
bilateral femoro-popliteal bypass surgery. Baseline
characteristics showed no significant differences
between the randomized groups as is shown in Table
1. In total 196 (60%) bypass procedures were
performed in men. The mean age of the patients at
the time of operation was 69 years (range 39–90 years).
Medical history of the participants was positive for
angina pectoris in 65 (20%), myocardial infarction in 81
(25%), TIA or CVA in 38 (12%), previous vascular
interventions in 152 (46%), smoking in 182 (55%),
hypertension in 143 (44%), diabetes mellitus in 94
(29%), and hypercholesterolemia in 52 (16%).The indication for surgery was intermittent claudi-
cation (Rutherford I) in 188 (55%) of the patients, rest
and/or night pain (Rutherford II) in 68 (21%) and
tissue loss (Rutherford III) in 72 (23%) patients (Table
2). Angiography showed 141 legs with three open run-
off vessels, 102 legs with two, 74 legs with one and 11
legs with no open run-off vessel (Table 2). There was
no significant difference between the ETE and the ETS
group for either the number of open run-off vessels or
the indication for surgery.
Only eight above knee venous bypasses were
constructed (three ETE and five ETS), Table 3. The
majority of the bypasses were above knee prosthetic
bypasses (53%, 84 ETE and 90 ETS) as PTFE was the
preferred material for above knee bypasses. Below
knee venous bypasses were constructed in 88 (27%) of
the procedures (41 ETE and 47 ETS). Below knee
prosthetic bypass surgery was required in 58 (18%) of
all bypasses (34 ETE and 24 ETS) because no adequate
long saphenous vein was available.Effectiveness of randomization and analysis
In total 162 bypass procedures were assigned to be
performed using the ETE technique and 166 the ETS
technique (Fig. 1). During three procedures an ETE
anastomosis was made instead of an ETS and in threeEur J Vasc Endovasc Surg Vol 29, May 2005
Table 3. Distribution of different types of bypasses and number of
patients on anticoagulants or antiplatelet therapy
ETE, NZ162 ETS, NZ166
Type of bypass
Above knee venous 3 (2%) 5 (3%)
Above knee prosthetic 84 (52%) 90 (54%)
Below knee venous 41 (25%) 47 (28%)
Below knee prosthetic 34 (21%) 24 (15%)
Postoperative medication
Oral anticoagulation 112 (67%) 116 (72%)
Antiplatelet 47 (31%) 41 (26%)
ETE, end-to-end; ETS, end-to-side.
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instead of an ETE anastomosis. These ‘cross-overs’
were due to technical considerations.
Analysis was performed on an ‘intention to treat’
basis, including all patients. However, in eight patients
(five ETE and three ETS) no bypass was constructed
due to anatomical considerations during surgery and
in seven (five ETE and two ETS) a femoro-crural
bypass was constructed. Therefore, patency and limb
salvage analysis also was performed after exclusion of
these 15 (4.6%) patients.
Three-year survival was 77% with no significant
difference between the ETE and ETS group (77 vs 76%,
pZ0.60). After 3 years 38 ETE and 35 ETS bypasses
remained for patency analysis (Fig. 1). In total 67
patients (20%) did not have a duplex scan or ABPI
measurement after 36 of follow-up. Twenty-two (33%)
of these patients had duplex or ABPI measure between
30 months and 36 months of follow-up. Of 59 patients
in the ETE group and 58 of the ETS group calculations
on major amputations could be performed (Fig. 2).Fig. 1. Kaplan–Meier analysis comparing primary bypass
patency in relation to distal ETS (end-to-side) and ETE (end-
to-end) anasomoses. Numbers at risk are shown on the x-axis
(ETE/ETS). —, ETE; — — —, ETS.
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Primary patency did not differ significantly between
the ETE and ETS group (Fig. 1). After 3 years primary
patency was 63 vs 55% for ETE and ETS anastomosed
bypasses, respectively. After correction for cardiovas-
cular risk factors, type of bypass, open run off vessels,
and Rutherford classification the difference was still
not significant (pZ0.268). Also after analysis without
the 15 patients in whom no femoropopliteal bypass
was constructed, the difference remained non-
significant (pZ0.439).
Primary patency also was calculated for each type
of bypass. The above knee venous bypasses were
excluded because of the low number (eight only).
Below knee venous bypasses had a better primary
patency rate, 75% after 3 years of follow up, than above
knee prosthetic bypasses, primary patency 55%. Below
knee prosthetic bypasses had the worst outcome,
primary patency of 45% after 3 years of follow up.Outcome after graft failure
A total of 98 (30%) bypasses occluded, 53 (32%) in the
ETS group and 45 (28%) in the ETE group. Occlusion
led to 20 (44%) major amputations in the ETE group
and nine (17%) major amputations in the ETS group;
limb salvage is presented in a Kaplan–Meier curve
(Fig. 2). This difference in limb salvage was significant,
after adjustment for confounding factors such as
diabetes, Rutherford classification, type of bypass,
and number of open run-off vessels pZ0.027. The
difference remained significant after exclusion of the
15 patients in whom no femoropopliteal bypass was
constructed.
Technical failure, i.e. occlusion of the bypass within
1 month after surgery, led to four amputations in the
ETS group and six in the ETE group. Therefore, five
amputations in the ETS group and 14 amputations in
the ETE group were not attributed to technical failure
(pZ0.028).
Of the 29 major amputations 12 were performed in
patients with diabetes mellitus, six in below knee
venous, 10 in below knee prosthetic, and 13 in the
above knee prosthetic bypasses. Eight patients who
eventually underwent amputations had disabling
claudication as indication for surgery, 10 had night
and/or rest pain, and 11 had already tissue loss at time
of surgery. Two patients with amputations had no
patent run-off vessels at time of surgery, eight had one
open run-off vessel, 12 had two and seven patients had
three open run-off vessels at time of surgery. Together
with type of distal anastomosis, the number of open
Fig. 2. Kaplan–Meier analysis comparing limb salvage in
relation to distal ETS (end-to-side) and ETE (end-to-end)
anasomoses. Numbers at risk are shown on the x-axis
(ETE/ETS). —, ETE; — — —, ETS.
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major amputations (pZ0.03).In hospital outcome
Median hospital stay was 12 days for both groups
(range 2–209 for the ETS and 0–229 for the ETE group).
During hospitalization 12 (7%) bypasses in the ETE
group and 11 (7%) in the ETS group occluded. Twelve
(7%) of the bypasses in the ETE group required
reintervention versus 19 (11%) in the ETS group.
Eventually seven (4%) major amputations (below knee
and higher) were performed in the ETE group versus
four (3%) in the ETS group. Thirteen (5%) patients (six
ETE and seven ETS) died in hospital, of which nine
(3%) deaths were within 30 days after surgery.Discussion
The VASCAN trial did not show that ETE distal
anastomoses improved patency after 3 years of follow
up. Limb salvage was superior in the ETS anasto-
mosed bypasses.
Our results for patency are comparable to other
reported multicenter trials. The superiority of auto-
logous vein over prosthetic grafts and above knee over
below knee bypasses is well known. Also the limb
salvage rate was similar as to that in previous
reports.11–22
The reasons underlying the worse limb salvage for
ETE distal anastomoses is not clear. Since, the
difference in limb salvage was caused principally by
an excess in amputations in the first 12 months for
distal ETE anastomosed bypasses, it is possible thatcollateral vessels play an important role. The use of
ETE anastomoses implies the exclusion of collateral
vessels, which have been developed prior to and
during the total occlusion of (parts) of the femoropo-
pliteal arterial segment. Consequently, in case of graft
failure the limb distal to the bypass is at high risk of
acute ischemia and subsequent complications. In
distal ETS anastomosed bypasses, the collateral vessel
system remains patent up to 12 months postopera-
tively (unpublished data). In the event of bypass
occlusion in the first year after surgery the collateral
vessels might protect against acute ischemia and the
subsequent need for amputation. After the first year,
the collateral vessels appear not to be functional. This
may explain the difference in limb salvage in the first
postoperative year and the almost equal rate of
amputations in later years.
In the only comparative clinical study of the
differences between ETE and ETS anastomoses pub-
lished so far there was no difference in limb salvage.10
However, that was a retrospective study. The influence
of preference and experience of the surgeon and
consequently the judgement of the intraoperative
anatomical situation could have been an important
confounder. In our prospective randomized trial these
biases were avoided.
This trial was established to clarify the potential
benefit of ETE anastomes over ETS anastomoses in
femoropopliteal bypasses based on theoretical and
experimental data suggesting better hemodynamic
properties and consequently less chance on intimal
hyperplasia in ETE anastomosed bypasses. However,
the in vivo measurement of intimal hyperplasia by
repeated angiography, IVUS or histology, is technically
difficult and time consuming. Since we did not obtain
quantitative data on intimal hyperplasia formation we
used patency as a surrogate marker of intimal
hyperplasia, particularly in the period between 1
month and 1 year after surgery. Therefore, we do not
have hard evidence that intimal hyperplasia formation
is similar in ETE and ETS anastomes in femoropopli-
teal bypasses but we feel justified, based on our data,
to proposing this conclusion.
Unfortunately, a substantial number of patients in
both groups were lost to follow up for patency
calculations, while limb salvage figures were almost
complete. This was because some patients did not
attend their scheduled follow up visit and further
information was obtained from the general practioner.
He or she could give accurate information on
amputations and hospitalizations but not on patency.
As in both the ETE and the ETS group a similar
proportion of patients were lost to follow up, it isEur J Vasc Endovasc Surg Vol 29, May 2005
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altered by more complete follow up.Conclusion
Despite the theoretical advantages of ETE over ETS
configuration for distal bypass anastomoses, the
VASCAN trial showed that there is no clinical
advantage. On the contrary, due to better limb salvage
in distal ETS anastomosed grafts the ETE technique for
distal anastomosis in femoropopliteal bypass surgery
should be used with reservation, using the ETS
technique and unless this is not feasible.Acknowledgements
This study was partially funded by an unrestricted research
grant of the ‘Lijf and Leven’ foundation, the Netherlands.Members of the VASCAN study group
B.C.V.M. Disselhoff (Department of Surgery, Mesos
Medical Center, Utrecht), T.H.A. Bikkers (Department
of Surgery, Lievensberg Hospital, Bergen op Zoom),
J.A. Kriele (Department of Surgery, Walcheren Hospi-
tal, Vlissingen), R.J. Dinkelman (Department of Sur-
gery, Medical Center Rotterdam Zuid, Rotterdam),
M.T.C. Hoedt (Department of Surgery, Albert Schweit-
zer Hospital, Dordrecht), W.C.J. Hop (Department of
Biostatistics, Erasmus MC, Rotterdam), C.H.A. Wit-
tens (Department of Surgery, Sint Fransiscus Gasthuis,
Rotterdam), O. Schouten, M.R.H.M. van Sambeek and
H. van Urk (Department of Vascular Surgery, Erasmus
MC, Rotterdam).References
1 Lemson MS, Tordoir JH, Daemen MJ, Kitslaart PJ. Intimal
hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg 2000;
19:336–350.
2 Bassiouny HS, White S, Glagov S et al. Anastomotic intimal
hyperplasia: mechanical injury or flow induced. J Vasc Surg 1992;
15(4):708–716 [discussion 716–7].
3 Ojha M. Wall shear stress temporal gradient and anastomotic
intimal hyperplasia. Circ Res 1994;74(6):1227–1231.
4 Sottiurai VS, Sue SL, Feinberg EL et al. Distal anastomotic
intimal hyperplasia: biogenesis and etiology. Eur J Vasc Surg 1988;
2(4):245–256.Eur J Vasc Endovasc Surg Vol 29, May 20055 Longest PW, Kleinstreuer C. Numerical simulation of wall
shear stress conditions and platelet localization in realistic end-
to-side arterial anastomoses. J Biomech Eng 2003;125(5):671–681.
6 Keynton RS, Evancho MM, Sims RL et al. Intimal hyperplasia
and wall shear in arterial bypass graft distal anastomoses: an in
vivo model study. J Biomech Eng 2001;123(5):464–473.
7 Haruguchi H, Teraoka S. Intimal hyperplasia and hemody-
namic factors in arterial bypass and arteriovenous grafts: a
review. J Artif Organs 2003;6(4):227–235.
8 Kim YH, Chandran KB, Bower TJ, Corson JD et al. Flow
dynamics across end-to-end vascular bypass graft anastomoses.
Ann Biomed Eng 1993;21(4):311–320.
9 Heise M, Kruger U, Ruckert R et al. Correlation of intimal
hyperplasia development and shear stress distribution at the
distal end-side-anastomosis, in vitro study using particle image
velocimetry. Eur J Vasc Endovasc Surg 2003;26(4):357–366.
10 Hoedt MTC, van Urk H, Hop WC et al. A comparison of distal
end-to-side and end-to-end anastomoses in femoropopliteal
bypasses. Eur J Vasc Endovasc Surg 2001;21(3):266–270.
11 Klinkert P, Schepers A, Burger DH et al. Vein versus
polytetrafluoroethylene in above-knee femoropopliteal bypass
grafting: five-year results of a randomized controlled trial. J Vasc
Surg 2003;37(1):149–155.
12 Veith FJ, Gupta SK, Ascer E et al. Six-year prospective
multicenter randomized comparison of autologous saphenous
vein and expanded polytetrafluoroethylene grafts in infraingu-
inal arterial reconstructions. J Vasc Surg 1986;3(1):104–114.
13 Stonebridge PA, Prescott RJ, Ruckley CV. Randomized trial
comparing infrainguinal polytetrafluoroethylene bypass grafting
with and without vein interposition cuff at the distal anastomo-
sis. The Joint Vascular Research Group. J Vasc Surg 1997;
26(4):543–550.
14 Griffiths GD, Nagy J, Black D, Stonebridge PA et al.
Randomized clinical trial of distal anastomotic interposition
vein cuff in infrainguinal polytetrafluoroethylene bypass graft-
ing. Br J Surg 2004;91(5):560–562.
15 AbuRahma AF, Robinson PA, Holt SM. Prospective controlled
study of polytetrafluoroethylene versus saphenous vein in
claudicant patients with bilateral above knee femoropopliteal
bypasses. Surgery 1999;126(4):594–601 [discussion 601–2].
16 Eagleton MJ, Ouriel K, Shortell C, Green RM. Femoral-
infrapopliteal bypass with prosthetic grafts. Surgery 1999;
126(4):759–764 [discussion 764–5].
17 Johnson WC, Lee KK. A comparative evaluation of polytetra-
fluoroethylene, umbilical vein, and saphenous vein bypass grafts
for femoral-popliteal above-knee revascularization: a prospective
randomized Department of Veterans Affairs cooperative study.
J Vasc Surg 2000;32(2):268–277.
18 Berlakovich GA, Herbst F, Mittlbock M, Kretschmer G. The
choice of material for above-knee femoropopliteal bypass. A 20-
year experience. Arch Surg 1994;129(3):297–302.
19 John TG, Stonebridge PA, Kelman J et al. Above-knee
femoropopliteal bypass grafts and the consequences of graft
failure. Ann R Coll Surg Engl 1993;75(4):257–260.
20 Hobson RW, Lynch TG, Jamil Z et al. Results of revasculariza-
tion and amputation in severe lower extremity ischemia: a five-
year clinical experience. J Vasc Surg 1985;2(1):174–185.
21 Quinones-Baldrich WJ, Prego AA, Ucelay-Gomez R et al.
Long-term results of infrainguinal revascularization with poly-
tetrafluoroethylene: a ten-year experience. J Vasc Surg 1992;
16(2):209–217.
22 Kent KC, Donaldson MC, Attinger CE et al. Femoropopliteal
reconstruction for claudication. The risk to life and limb. Arch
Surg 1988;123(10):1196–1198.
Accepted 17 January 2005
Available online 17 February 2005
